Using syngeneic breast cancer models in mice, we have shown that obesity leads to the NLRC4-inflammasome-mediated activation of IL-1β in infiltrating macrophages, which in turn promotes increased angiogenesis and disease progression. This evidence concerns the gene NLRC4 and breast carcinoma.